Understanding “Hybrid Immunity”: Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) VaccinesNusrat J Epsi, Jennifer A. Rusiecki, Mark P. Simons et al.|Clinical Infectious Diseases|2022Cited by 59
Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019Stephanie A Richard, M. Wayman, Nusrat J Epsi et al.|Open Forum Infectious Diseases|2021Cited by 36
A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptomsNusrat J Epsi, John H. Powers, David A Lindholm et al.|PLoS ONE|2023Cited by 21
Precision Symptom Phenotyping Identifies Early Clinical and Proteomic Predictors of Distinct COVID-19 SequelaeNusrat J Epsi, Stephanie A Richard, Josh Chenoweth et al.|The Journal of Infectious Diseases|2024Cited by 18
COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to HealthStephanie A Richard, Josh Chenoweth, Nusrat J Epsi et al.|Open Forum Infectious Diseases|2022Cited by 14